Close Menu

USC

Epic will access the center's liquid biopsy samples and expand its platform to in-depth characterization of cell-free fractions and circulating tumor cells.

Presenters at the 2019 annual meeting's opening plenary spoke about merging technologies in order to individualize care for their patients.